U.S. Food and Drug Administration. Center for drug evaluation and research. Pediatric Exclusivity Labeling Changes as of July 14, 2006. Available from URL; http://www.fda.gov/cder/pediatric/labelchange.htm.
Parke TJ, Steven JE, Rice AS, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992; 305:613–66.
Withington D, Decell MK, Al Ayed T. A case of propofol toxicity: further evidence for a causal mechanism. Pediatr Anesth 2004; 14:505–88.
Kang TM. Propofol infusion syndrome in critically ill patients. Ann Pharmacother 2002; 36:1453–6.
Reynolds JE. Martindale’s The Extra Pharmacopoeia, 29th ed. London: The Pharmaceutical Press; 1989:949–72..
Saravanakumar K, Venkatesh P, Bromley P. Delayed onset refractory dystonic movements following propofol anesthesia. Pediatr Anesth 2005; 15:597–6011.
Al-Jahdari WS, Saito S, Nakano T, Goto F. Propofol induces growth cone collapse and neurite retractions in chick explant culture. Can J Anesth 2006; 53:1078–855.
Kandel ER, Schwartz JH, Jessell TM. Principles of Neural Science, 4th ed. New York: McGraw-Hill; 2000: 1070–4.
Jauniaux E, Gulbis B, Shannon C, Maes V, Bromley L, Rodeck C. Placental propofol transfer and fetal sedation during maternal general anaesthesia in early pregnancy. Lancet 1998; 352: 290–1.
Gin T, Gregory MA, Chan K, Oh TE. Maternal and fetal levels of propofol at caesarean section. Anaesth Intensive Care 1990; 18:180–4..
Peeters MY, Prins SA, Knibbe CA, et al. Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery. Anesthesiology 2006; 104: 466–74.
Raoof AA, van Obbergh LJ, Verbeeck RK. Propofol pharmacokinetics in children with biliary atresia. Br J Anaesth 1995; 74:46–9..
Knibbe CA, Melenhorst-de Jong G, Mestrom M, et al. Pharmacokinetics and effects of propofol 6% for short-term sedation in paediatric patients following cardiac surgery. Br J Clin Pharmacol 2002; 54:415–222.
Murat I, Billard V, Vernois J, et al. Pharmacokinetics of propofol after a single dose in children aged 1-3 years with minor burns. Comparison of three data analysis approaches. Anesthesiology 1996; 84:526–322.
Health Canada. Therapeutic product directorate. Important safety concerns re use of propofol for sedation in pediatric patients. Health Products and Food Branch. Notice to Hospitals. May 1, 2001. Available from URL; http://www.hs-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/2001/index_ehtm.
About this article
Cite this article
Beheiry, H.E., Kavanagh, B. Is propofol neurotoxic to the developing brain?. Can J Anesth 53, 1069 (2006). https://doi.org/10.1007/BF03022872